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304 Abstracts / Contraception 90 (2014) 298–3514.2% of women with no prior scarring needed additional intervention
(aOR 1.7, 95% CI 0.87–3.2).
Conclusions: We did not find a significant association between uterine
scarring and medication abortion using the current evidence-based
regimen, although our findings do not rule out the possibility of a modest
association. Overall, our findings support the continued provision of this
regimen to women with uterine scarring. This is the largest sample size in
which this association has been studied, and our findings are consistent
with previous studies of other regimens.
http://dx.doi.org/10.1016/j.contraception.2014.05.041
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Objectives:We aimed to conduct evidence-based advocacy informed by the
policy landscape in Oklahoma and Oklahoma women’s experiences
accessing reproductive health care.
Methods:We first examined state-level policies and outcomes specific to
the health and socioeconomic well-being of women and children and
determined how those policies and outcomes related to the number of
state-level abortion restrictions. We then conducted in-depth interviews
with Oklahoma women who recently had abortions about their experiences
with abortion, pregnancy, maternal and child care, and other health care.
In-depth interviews were recorded, transcribed and analyzed thematically.
Findings were shared with state-level advocates to develop a plan for
responding to women’s unmet needs.
Results: The state policy and outcomes analysis showed that Oklahoma
heavily restricts abortion, has few policies in place that support women’s
and children’s health, and performs poorly on indicators of women’s and
children’s health and socioeconomic well-being. In-depth interviewees
described difficulty accessing health insurance, primary health care and
abortion services in contrast to the relative ease with which they described
accessing prenatal and child health care. To address these issues, advocates
called for collaborative efforts by stakeholders focused on improving
abortion access, social determinants of health, and women’s and children’s
overall health.
Conclusions: These data highlight the need for Oklahoma policymakers
to focus on evidence-based policies known to support women’s and
children’s health instead of abortion restrictions, which have no health
benefits and can be harmful to women. It also highlights the need to
consider women’s abortion care needs in the context of their broader
health care needs.
http://dx.doi.org/10.1016/j.contraception.2014.05.042
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Objectives: Since the Supreme Court upheld the partial birth abortion
ban in 2007, more U.S. abortion providers have begun performingintraamniotic digoxin injections prior to uterine dilation and
evacuations. These injections can cause medical harm to abortion
patients. Our objective was to perform an in-depth bioethical analysis
of this procedure, which is performed mainly for the provider’s legal
benefit despite potential medical consequences for the patient.
Methods: Several kinds of situations in medicine when medical risk or
harm to a patient can be ethically justified were analyzed. First, patients
may be ethically subjected to risk for the benefit of others, as in the cases
of organ donation or public health measures. Second, patients may be
subject to medical risk to avoid a rare but catastrophic outcome, such as
exposing a patient to CT radiation to rule out an unlikely but devastating
intracranial hemorrhage. Finally, patients may face risk because of
providers’ compliance with a restrictive law, such as when laws
mandating parental consent for abortion result in diminished access
for patients.
Results: While examples exist in medicine where patients are ethically
subjected to medical risk, they differ from the case of digoxin injection in
important ways. These injections lack the potential to benefit third parties;
do not help prevent rare but catastrophic outcomes; and represent direct,
medical harm not mandated by law.
Conclusions: Digoxin injections subject patients to risk to preserve the
availability of legal abortion in their community; whether such a tradeoff
can be ethically condoned requires explicit discussion among physicians
and patients.
http://dx.doi.org/10.1016/j.contraception.2014.05.043
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Objectives: To compare the efficacy and complication rates of medical
abortion versus surgical abortion up to 9 weeks’ gestation.
Methods: We performed an historical cohort study comparing outcomes
of first-trimester medical abortion versus surgical abortion at Planned
Parenthood, Los Angeles from November 2010 to August 2013. Data
were collected through electronic medical record review from 30,147
women with pregnancies at or less than 63 days’ gestation seeking
termination. Charts were reviewed for complications occurring within the
immediate postabortion period (within 8 weeks). These included
unanticipated aspiration, ongoing pregnancy and other adverse events
(emergency room presentation, hospitalization, perforation, transfusion,
infection). Chi square test and logistic regression were used to compare
the primary outcomes between cohorts.
Results: Social, demographic and clinical characteristics were similar in
the medication abortion and surgical abortion groups. Unadjusted rates of
ongoing pregnancy were low in both groups at 0.39% for medication
abortions and 0.17% for surgical abortions (pb.0001). The medication
abortion group was more likely to undergo an unanticipated aspiration
for persistent bleeding or ongoing pregnancy, (1.63% vs. 0.51% of the
surgical abortion group, pb.001). These rates were unchanged after we
controlled for age, gravidity, parity, body mass index and gestational
age. There was no difference in other adverse events between the
two groups.
Conclusions: Medication abortion and surgical abortion at or prior to
63 days’ gestation are both safe and effective. Women should be offered
both options when seeking pregnancy termination up to 9 weeks’ gestation.
http://dx.doi.org/10.1016/j.contraception.2014.05.044
